Continuing Education Credit Information

Conference Description

Breast cancer is the most common cancer affecting women. Diagnosis and treatments are part of the practice of a wide number of medical specialists and there are national initiatives calling for a multidisciplinary approach to the care of breast cancer patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important due to of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient.

The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy, both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.

This three-day symposium will evaluate and discuss different models for coordination of breast cancer care from major centers across the United States. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols for the local treatment of breast cancer.

Target Audience

This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted for general, plastic, breast and oncologic surgeons, as well as radiation and medical oncologists. It is also intended for primary care physicians, oncology nurses and practitioners, physical therapists, occupational therapists, genetic counselors, hospital administrators and other members of the healthcare team who have an interest in the treatment of breast cancer patients.

Learning Objectives

  • Recognize the important controversial aspects of coordinated local treatment of breast cancer and breast reconstruction.

  • Identify the risks and benefits of prophylactic mastectomy.

  • Implement surgical techniques designed to improve the likelihood of nipple preservation and reduce the risk of flap or nipple necrosis with mastectomy.

  • Recognize the impact of reconstruction on post-mastectomy radiation delivery and, conversely, of the impact of post-mastectomy radiation on prior reconstruction.

  • Describe different philosophies regarding radiation delivery including new techniques and how to minimize side effects to the surrounding tissue.

  • Describe the risk and benefits of re-staging patients after neoadjuvant chemotherapy.

  • Describe the pros and cons of downstaging based upon response to chemotherapy pre-mastectomy on the subsequent treatment plan, the scope and power of oncoplastic surgery in the patient who undergoes breast conservation therapy for breast cancer, and the arguments in favor of a coordinated team approach in oncoplastic surgery to maximize the cosmetic and oncologic outcomes.

  • Identify the different methods of breast reconstruction including implant-based reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction.

  • Utilize proper patient selection and timing for breast reconstruction procedures as well as the evolving role of alloplastic materials in breast reconstruction both in terms of enhancing and facilitating device reconstruction of the breast, as well as reconstructing the abdomen after flap harvesting.

  • Recognize the disparities that exist with different populations and their respective access to reconstructive surgery.

  • Understand the new options available to surgically treat patients with lymphedema.

  • Recognize the impact that financial toxicity related to the care of breast cancer can have on access to care and on outcomes.

  • Appreciate the state-of-the-art techniques in oncoplastic surgery, lymphatic


In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Financial Relationships with Any Commercial Interest

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), it is the policy of MedStar Health to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity.

The Joint Accreditation considers relationships of the person involved in the CE activity to include financial relationships of a spouse or partner. Any individual who refuses to disclose relevant financial relationships will be disqualified from participating in the CE activity.


This continuing medical education activity is supported by unrestricted educational grants, exhibits, and commercial support from contributing organizations, each of which will be identified in course materials at the conference.